Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Chris W. who wrote (2668)	3/23/2000 10:37:00 AM
From: Walter Morton	Read Replies (1) \| Respond to of 2742

There are 20 million shares outstanding. If they only own 500,000 shares collectively they, won't be much help.

To: Chris W. who wrote (2668)	3/24/2000 10:51:00 AM
From: Walter Morton	Respond to of 2742

Well, I sent an email to Catherine Feddersen at the Wellesley College Treasurer's Office, but have not received a response. I'm still trying to find Mitch Creem's email address.

To: Chris W. who wrote (2668)	3/28/2000 11:53:00 PM
From: Walter Morton	Respond to of 2742

<<The parties to the Amended License Agreement have consented to the Merger>> ...On March 21, 2000, the Company and the Massachusetts Institute of Technology, New England Medical Center Hospitals, Inc., Trustees of Tufts College, Tufts University School of Medicine and Wellesley College (collectively, the "Licensors") amended the license agreement ("Amended License Agreement") that the parties first entered into on December 2, 1983. ___ It appears that CIST's largest investors have already agreed to the merger. It's a done deal unless another company makes an offer for more than what CLL offered plus $500,000 (the penalty for rejecting CLL's offer).